Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07457099
What this trial is testing

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Oral Squamous Cell CarcinomaLocally Advanced Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital 85
Large-scale testing (Phase 3)UnknownNCT04799314
What this trial is testing

PD-1 Inhibitor Tislelizumab Maintenance Therapy in R/R DLBCL Patients After ASCT

Who this might be right for
Lymphoma, Large B-Cell, DiffuseTransplantationChemotherapy
Ruijin Hospital 132
Testing effectiveness (Phase 2)Looking for participantsNCT07403136
What this trial is testing

Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 104
Large-scale testing (Phase 3)Not Yet RecruitingNCT07827872
What this trial is testing

Neoadjuvant Sintilimab Plus Chemotherapy for cT2N0M0 Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Head and Neck Squamous Cell CarcinomaEarly-stage Oral Cancer
caohaotian 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06894459
What this trial is testing

A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancers
Beijing Tongren Hospital 180
Testing effectiveness (Phase 2)UnknownNCT05760196
What this trial is testing

Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors

Who this might be right for
Objective Response Rate
Xiangpan Li 56
Testing effectiveness (Phase 2)UnknownNCT05137886
What this trial is testing

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRelapseRefractory Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 47
Large-scale testing (Phase 3)Study completedNCT04472429
What this trial is testing

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation 308
Not applicableNot Yet RecruitingNCT07674342
What this trial is testing

Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma

Who this might be right for
Locally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma
Tongji Hospital 146
Not applicableNot Yet RecruitingNCT07684066
What this trial is testing

D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Advanced Cutaneous Squamous Cell CarcinomaMetastatic Cutaneous Squamous Cell Carcinoma
Universitätsklinikum Hamburg-Eppendorf 116
Early research (Phase 1)Not Yet RecruitingNCT07472790
What this trial is testing

A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma

Who this might be right for
High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd 15
Not applicableNot Yet RecruitingNCT07392073
What this trial is testing

Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC

Who this might be right for
Non-Small Cell Lung CancerLung AdenocarcinomaLung Squamous Cell Carcinoma+3 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 80
Not applicableLooking for participantsNCT06635954
What this trial is testing

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Who this might be right for
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc. 2,000
Early research (Phase 1)Temporarily pausedNCT04840589
What this trial is testing

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Platinum-Resistant Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06957977
What this trial is testing

Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer

Who this might be right for
Gastric CancerCryoballoon Ablation
Zhongguang Luo, MD 42
Early research (Phase 1)Study completedNCT04105335
What this trial is testing

MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT)

Who this might be right for
Solid Tumor, Adult
Mina Alpha Limited 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07133776
What this trial is testing

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

Who this might be right for
Epstein-Barr Virus (EBV) InfectionPD-1 InhibitorTenofovir+2 more
The Affiliated Hospital of Xuzhou Medical University 30
Not applicableLooking for participantsNCT07652125
What this trial is testing

RGL-270 + ICI in Advanced NSCLC

Who this might be right for
NSCLC
Guangdong Association of Clinical Trials 40
Early research (Phase 1)Looking for participantsNCT07285395
What this trial is testing

AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study

Who this might be right for
Advanced Solid Tumors
The Affiliated Hospital of Xuzhou Medical University 12
Testing effectiveness (Phase 2)UnknownNCT04091932
What this trial is testing

Treatment of PD-1 Inhibitor in AIDS-associated PML

Who this might be right for
Progressive Multifocal LeukoencephalopathyAIDS
First Affiliated Hospital of Zhejiang University 10
Next Page